Intensity of Renal Support in Critically Ill Patients with Acute Kidney InjuryRobert A. Star, Mark W. Smith, Kathleen M. Swanson et al.|New England Journal of Medicine|2008Cited by 1.8k
Treatment of Septic Shock with the Tumor Necrosis Factor Receptor:Fc Fusion ProteinCharles J. Fisher, Ernest Benjamin, Jan M. Agosti et al.|New England Journal of Medicine|1996Cited by 1.3k
Effect of Eritoran, an Antagonist of MD2-TLR4, on Mortality in Patients With Severe SepsisSteven M. Opal, for the ACCESS Study Group, Pierre‐François Laterre et al.|JAMA|2013Cited by 797
Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsisCharles J. Fisher, Jerald Sadoff, Steven M. Opal et al.|Critical Care Medicine|1993Cited by 431
Effect of Eritoran, an Antagonist of MD2-TLR4, on Mortality in Patients With Severe SepsisSteven M. Opal, Daniel P. Rossignol, Pierre‐François Laterre et al.|Unknown|2013Cited by 7